Clinical Trial Detail

NCT ID NCT02030483
Title Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications

multiple myeloma

Therapies

Palbociclib

Dexamethasone

Lenalidomide

Age Groups: adult

Additional content available in CKB BOOST